#begin document (nw/wsj/06/wsj_0690); part 000
nw/wsj/06/wsj_0690   0    0        Federal     JJ          (TOP(S(NP(NP*          -    -   -   -        *   (ARG1*            *         *   (ARG0*         *        *             *   -
nw/wsj/06/wsj_0690   0    1           drug     NN                      *          -    -   -   -        *        *            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0    2     regulators    NNS                      *)         -    -   -   -        *        *)           *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0    3              ,      ,                      *          -    -   -   -        *        *            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0    4      concerned    VBN                 (ADJP*     concern  01   -   -        *      (V*)           *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0    5           over     IN                   (PP*          -    -   -   -        *   (ARG0*            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0    6        British     JJ                   (NP*          -    -   -   -    (NORP)       *            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0    7        reports    NNS                      *          -    -   -   -        *        *            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0    8           that     IN                 (SBAR*          -    -   -   -        *        *            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0    9      diabetics    NNS                 (S(NP*)         -    -   -   -        *        *       (ARG1*)   (ARG0*)       *         *        *             *   -
nw/wsj/06/wsj_0690   0   10           have    VBP                   (VP*          -    -   -   -        *        *            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0   11           died    VBN                   (VP*         die  01   -   -        *        *          (V*)        *        *         *        *             *   -
nw/wsj/06/wsj_0690   0   12          after     IN                   (PP*          -    -   -   -        *        *   (ARGM-TMP*         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0   13       shifting    VBG                 (S(VP*       shift  01   2   -        *        *            *       (V*)       *         *        *             *   -
nw/wsj/06/wsj_0690   0   14           from     IN                   (PP*          -    -   -   -        *        *            *    (ARG3*        *         *        *             *   -
nw/wsj/06/wsj_0690   0   15         animal     JJ                (ADJP*))         -    -   -   -        *        *            *         *)       *         *        *             *   -
nw/wsj/06/wsj_0690   0   16             to     IN                   (PP*          -    -   -   -        *        *            *    (ARG2*        *         *        *             *   -
nw/wsj/06/wsj_0690   0   17          human     NN              (NP(ADJP*          -    -   -   -        *        *            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0   18             -    HYPH                      *          -    -   -   -        *        *            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0   19          based    VBN                      *)         -    -   -   -        *        *            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0   20        insulin     NN           *))))))))))))         -    -   -   -        *        *)           *)        *)       *         *        *             *   -
nw/wsj/06/wsj_0690   0   21              ,      ,                      *)         -    -   -   -        *        *            *         *        *)        *        *             *   -
nw/wsj/06/wsj_0690   0   22            say    VBP                   (VP*         say  01   -   -        *        *            *         *      (V*)        *        *             *   -
nw/wsj/06/wsj_0690   0   23           they    PRP            (SBAR(S(NP*)         -    -   -   -        *        *            *         *   (ARG1*    (ARG0*)       *             *   -
nw/wsj/06/wsj_0690   0   24            are    VBP                   (VP*          -    -   -   -        *        *            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0   25    considering    VBG                   (VP*    consider  01   -   -        *        *            *         *        *       (V*)       *             *   -
nw/wsj/06/wsj_0690   0   26              a     DT                (NP(NP*          -    -   -   -        *        *            *         *        *    (ARG1*   (ARG0*             *   -
nw/wsj/06/wsj_0690   0   27          study     NN                      *)         -    -   -   -        *        *            *         *        *         *        *)            *   -
nw/wsj/06/wsj_0690   0   28             to     TO            (SBAR(S(VP*          -    -   -   -        *        *            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0   29            see     VB                   (VP*         see  01   -   -        *        *            *         *        *         *      (V*)            *   -
nw/wsj/06/wsj_0690   0   30             if     IN                 (SBAR*          -    -   -   -        *        *            *         *        *         *   (ARG1*             *   -
nw/wsj/06/wsj_0690   0   31        similar     JJ                 (S(NP*          -    -   -   -        *        *            *         *        *         *        *        (ARG1*   -
nw/wsj/06/wsj_0690   0   32         deaths    NNS                      *)         -    -   -   -        *        *            *         *        *         *        *             *)  -
nw/wsj/06/wsj_0690   0   33           have     VB                   (VP*          -    -   -   -        *        *            *         *        *         *        *             *   -
nw/wsj/06/wsj_0690   0   34       occurred    VBN                   (VP*       occur  01   -   -        *        *            *         *        *         *        *           (V*)  -
nw/wsj/06/wsj_0690   0   35           here     RB   (ADVP*)))))))))))))))         -    -   -   -        *        *            *         *        *)        *)       *)   (ARGM-LOC*)  -
nw/wsj/06/wsj_0690   0   36              .      .                     *))         -    -   -   -        *        *            *         *        *         *        *             *   -

nw/wsj/06/wsj_0690   0    0          The    DT    (TOP(S(NP*      -    -   -   -          *   (ARG1*   -
nw/wsj/06/wsj_0690   0    1       United   NNP         (NML*      -    -   -   -      (GPE*        *   -
nw/wsj/06/wsj_0690   0    2      Kingdom   NNP             *)     -    -   -   -          *)       *   -
nw/wsj/06/wsj_0690   0    3      reports   NNS             *)     -    -   -   -          *        *)  -
nw/wsj/06/wsj_0690   0    4         came   VBD          (VP*    come  03   -   -          *      (V*)  -
nw/wsj/06/wsj_0690   0    5         from    IN          (PP*      -    -   -   -          *   (ARG2*   -
nw/wsj/06/wsj_0690   0    6          Dr.   NNP       (NP(NP*      -    -   -   -          *        *   -
nw/wsj/06/wsj_0690   0    7      Patrick   NNP             *      -    -   -   -   (PERSON*        *   -
nw/wsj/06/wsj_0690   0    8     Toseland   NNP             *)     -    -   -   -          *)       *   -
nw/wsj/06/wsj_0690   0    9            ,     ,             *      -    -   -   -          *        *   -
nw/wsj/06/wsj_0690   0   10         head    NN       (NP(NP*)     -    -   -   -          *        *   -
nw/wsj/06/wsj_0690   0   11           of    IN          (PP*      -    -   -   -          *        *   -
nw/wsj/06/wsj_0690   0   12     clinical    JJ          (NP*      -    -   -   -          *        *   -
nw/wsj/06/wsj_0690   0   13    chemistry    NN            *))     -    -   -   -          *        *   -
nw/wsj/06/wsj_0690   0   14           at    IN          (PP*      -    -   -   -          *        *   -
nw/wsj/06/wsj_0690   0   15          Guy   NNP    (NP(NP(NP*      -    -   -   -      (ORG*        *   -
nw/wsj/06/wsj_0690   0   16           's   POS             *)     -    -   -   -          *        *   -
nw/wsj/06/wsj_0690   0   17     Hospital   NNP             *)     -    -   -   -          *)       *   -
nw/wsj/06/wsj_0690   0   18           in    IN          (PP*      -    -   -   -          *        *   -
nw/wsj/06/wsj_0690   0   19       London   NNP   (NP*))))))))     -    -   -   -       (GPE)       *)  -
nw/wsj/06/wsj_0690   0   20            .     .            *))     -    -   -   -          *        *   -

nw/wsj/06/wsj_0690   0    0             In    IN         (TOP(S(PP*     -    -   -   -            *    (ARGM-LOC*            *        *   -
nw/wsj/06/wsj_0690   0    1              a    DT               (NP*     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0    2      telephone    NN                  *     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0    3      interview    NN                 *))    -    -   -   -            *             *)           *        *   -
nw/wsj/06/wsj_0690   0    4         Friday   NNP               (NP*)    -    -   -   -        (DATE)   (ARGM-TMP*)           *        *   -
nw/wsj/06/wsj_0690   0    5              ,     ,                  *     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0    6            Dr.   NNP               (NP*     -    -   -   -            *        (ARG0*            *        *   -
nw/wsj/06/wsj_0690   0    7       Toseland   NNP                  *)    -    -   -   -      (PERSON)            *)           *        *   -
nw/wsj/06/wsj_0690   0    8           said   VBD               (VP*    say  01   -   -            *           (V*)           *        *   -
nw/wsj/06/wsj_0690   0    9            the    DT  (SBAR(S(NP(NP(NP*     -    -   -   -            *        (ARG1*       (ARG1*   (ARG1*   -
nw/wsj/06/wsj_0690   0   10         number    NN                  *)    -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0   11             of    IN               (PP*     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0   12         sudden    JJ            (NP(NP*     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0   13              ,     ,                  *     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0   14    unexplained    JJ                  *     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0   15         deaths   NNS                  *)    -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0   16             of    IN               (PP*     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0   17      diabetics   NNS           (NP*)))))    -    -   -   -            *             *            *)       *   -
nw/wsj/06/wsj_0690   0   18             he   PRP        (SBAR(S(NP*)    -    -   -   -            *             *       (ARG0*)       *   -
nw/wsj/06/wsj_0690   0   19            had   VBD               (VP*     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0   20           seen   VBN               (VP*    see  01   -   -            *             *          (V*)       *   -
nw/wsj/06/wsj_0690   0   21           this    DT               (NP*     -    -   -   -       (DATE*             *   (ARGM-TMP*        *   -
nw/wsj/06/wsj_0690   0   22           year    NN             *))))))    -    -   -   -            *)            *            *)       *)  -
nw/wsj/06/wsj_0690   0   23            was   VBD               (VP*     be  01   -   -            *             *            *      (V*)  -
nw/wsj/06/wsj_0690   0   24            17     CD            (NP(NP*)    -    -   -   -    (CARDINAL)            *            *   (ARG2*   -
nw/wsj/06/wsj_0690   0   25       compared   VBN               (PP*     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0   26           with    IN               (PP*     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0   27           just    RB         (NP(NP(QP*     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0   28            two    CD                 *))    -    -   -   -    (CARDINAL)            *            *        *   -
nw/wsj/06/wsj_0690   0   29             in    IN               (PP*     -    -   -   -            *             *            *        *   -
nw/wsj/06/wsj_0690   0   30          1985     CD      (NP*))))))))))    -    -   -   -        (DATE)            *)           *        *)  -
nw/wsj/06/wsj_0690   0   31              .     .                 *))    -    -   -   -            *             *            *        *   -

nw/wsj/06/wsj_0690   0    0            At    RB  (TOP(S(S(NP(NP(QP(ADVP*        -    -   -   -   (CARDINAL*       (ARG1*            *    (ARG1*   -
nw/wsj/06/wsj_0690   0    1         least   RBS                        *)       -    -   -   -            *            *            *         *   -
nw/wsj/06/wsj_0690   0    2           six    CD                       *))       -    -   -   -            *)           *            *         *   -
nw/wsj/06/wsj_0690   0    3            of    IN                     (PP*        -    -   -   -            *            *            *         *   -
nw/wsj/06/wsj_0690   0    4           the    DT                     (NP*        -    -   -   -            *            *            *         *   -
nw/wsj/06/wsj_0690   0    5        deaths   NNS                      *)))       -    -   -   -            *            *)           *         *   -
nw/wsj/06/wsj_0690   0    6      occurred   VBD                     (VP*     occur  01   -   -            *          (V*)           *         *   -
nw/wsj/06/wsj_0690   0    7         among    IN                     (PP*        -    -   -   -            *   (ARGM-LOC*            *         *   -
nw/wsj/06/wsj_0690   0    8    relatively    RB             (NP(NP(ADJP*        -    -   -   -            *            *       (ARG0*         *   -
nw/wsj/06/wsj_0690   0    9         young    JJ                        *)       -    -   -   -            *            *            *         *   -
nw/wsj/06/wsj_0690   0   10     diabetics   NNS                        *)       -    -   -   -            *            *            *)        *   -
nw/wsj/06/wsj_0690   0   11           who    WP              (SBAR(WHNP*)       -    -   -   -            *            *     (R-ARG0*)        *   -
nw/wsj/06/wsj_0690   0   12           had   VBD                   (S(VP*        -    -   -   -            *            *            *         *   -
nw/wsj/06/wsj_0690   0   13      switched   VBN                     (VP*    switch  01   1   -            *            *          (V*)        *   -
nw/wsj/06/wsj_0690   0   14          from    IN                     (PP*        -    -   -   -            *            *       (ARG3*         *   -
nw/wsj/06/wsj_0690   0   15        animal    NN                    (NP*))       -    -   -   -            *            *            *)        *   -
nw/wsj/06/wsj_0690   0   16            to    IN                     (PP*        -    -   -   -            *            *       (ARG2*         *   -
nw/wsj/06/wsj_0690   0   17         human    JJ                     (NP*        -    -   -   -            *            *            *         *   -
nw/wsj/06/wsj_0690   0   18       insulin    NN                       *))       -    -   -   -            *            *            *)        *   -
nw/wsj/06/wsj_0690   0   19        within    IN                     (PP*        -    -   -   -            *            *   (ARGM-TMP*         *   -
nw/wsj/06/wsj_0690   0   20           the    DT                     (NP*        -    -   -   -       (DATE*            *            *         *   -
nw/wsj/06/wsj_0690   0   21          past    JJ                        *        -    -   -   -            *            *            *         *   -
nw/wsj/06/wsj_0690   0   22          year    NN               *))))))))))       -    -   -   -            *)           *)           *)        *)  -
nw/wsj/06/wsj_0690   0   23             ,     ,                        *        -    -   -   -            *            *            *         *   -
nw/wsj/06/wsj_0690   0   24            he   PRP                     (NP*)       -    -   -   -            *            *            *    (ARG0*)  -
nw/wsj/06/wsj_0690   0   25          said   VBD                     (VP*)      say  01   -   -            *            *            *       (V*)  -
nw/wsj/06/wsj_0690   0   26             .     .                       *))       -    -   -   -            *            *            *         *   -

nw/wsj/06/wsj_0690   0    0               Dr.   NNP  (TOP(S(NP(NP*         -    -   -   -          *   (ARG0*            *   -
nw/wsj/06/wsj_0690   0    1           Solomon   NNP              *         -    -   -   -   (PERSON*        *            *   -
nw/wsj/06/wsj_0690   0    2             Sobel   NNP              *)        -    -   -   -          *)       *            *   -
nw/wsj/06/wsj_0690   0    3                 ,     ,              *         -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0    4          director    NN        (NP(NP*)        -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0    5                of    IN           (PP*         -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0    6        metabolism    NN       (NP(UCP*         -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0    7               and    CC              *         -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0    8        endrocrine    JJ              *)        -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0    9              drug    NN              *         -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0   10          products   NNS             *))        -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0   11               for    IN           (PP*         -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0   12               the    DT           (NP*         -    -   -   -      (ORG*        *            *   -
nw/wsj/06/wsj_0690   0   13              U.S.   NNP              *         -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0   14              Food   NNP          (NML*         -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0   15               and    CC              *         -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0   16              Drug   NNP              *)        -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0   17    Administration   NNP            *)))        -    -   -   -          *)       *            *   -
nw/wsj/06/wsj_0690   0   18                 ,     ,              *)        -    -   -   -          *        *)           *   -
nw/wsj/06/wsj_0690   0   19              said   VBD           (VP*        say  01   -   -          *      (V*)           *   -
nw/wsj/06/wsj_0690   0   20               FDA   NNP    (SBAR(S(NP*         -    -   -   -       (ORG)  (ARG1*       (ARG0*   -
nw/wsj/06/wsj_0690   0   21         officials   NNS              *)        -    -   -   -          *        *            *)  -
nw/wsj/06/wsj_0690   0   22              have   VBP           (VP*         -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0   23         discussed   VBN           (VP*    discuss  01   1   -          *        *          (V*)  -
nw/wsj/06/wsj_0690   0   24               Dr.   NNP        (NP(NP*         -    -   -   -          *        *       (ARG1*   -
nw/wsj/06/wsj_0690   0   25          Toseland   NNP              *         -    -   -   -    (PERSON)       *            *   -
nw/wsj/06/wsj_0690   0   26                's   POS              *)        -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0   27          findings   NNS              *)        -    -   -   -          *        *            *)  -
nw/wsj/06/wsj_0690   0   28                ``    ``              *         -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0   29            fairly    RB         (ADVP*         -    -   -   -          *        *   (ARGM-MNR*   -
nw/wsj/06/wsj_0690   0   30       intensively    RB         *))))))        -    -   -   -          *        *)           *)  -
nw/wsj/06/wsj_0690   0   31                 .     .              *         -    -   -   -          *        *            *   -
nw/wsj/06/wsj_0690   0   32                ''    ''             *))        -    -   -   -          *        *            *   -

nw/wsj/06/wsj_0690   0    0          While     IN    (TOP(S(SBAR*          -    -   -   -          *        *   (ARGM-ADV*        *        *   -
nw/wsj/06/wsj_0690   0    1          there     EX          (S(NP*)         -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0    2           have    VBP            (VP*          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0    3           been    VBN            (VP*          be  02   -   -          *      (V*)           *        *        *   -
nw/wsj/06/wsj_0690   0    4             no     DT         (NP(NP*          -    -   -   -          *   (ARG1*            *        *        *   -
nw/wsj/06/wsj_0690   0    5        reports    NNS               *)         -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0    6             of     IN            (PP*          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0    7        similar     JJ         (NP(NP*          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0    8         sudden     JJ               *          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0    9    unexplained     JJ               *          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   10         deaths    NNS               *)         -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   11          among     IN            (PP*          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   12      diabetics    NNS         (NP(NP*)         -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   13             in     IN            (PP*          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   14            the     DT            (NP*          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   15           U.S.    NNP     *)))))))))))         -    -   -   -       (GPE)       *)           *)       *        *   -
nw/wsj/06/wsj_0690   0   16              ,      ,               *          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   17            Dr.    NNP            (NP*          -    -   -   -          *        *       (ARG0*        *        *   -
nw/wsj/06/wsj_0690   0   18          Sobel    NNP               *)         -    -   -   -    (PERSON)       *            *)       *        *   -
nw/wsj/06/wsj_0690   0   19           said    VBD            (VP*         say  01   -   -          *        *          (V*)       *        *   -
nw/wsj/06/wsj_0690   0   20            the     DT     (SBAR(S(NP*          -    -   -   -          *        *       (ARG1*   (ARG0*   (ARG0*   -
nw/wsj/06/wsj_0690   0   21            FDA    NNP               *)         -    -   -   -       (ORG)       *            *        *)       *)  -
nw/wsj/06/wsj_0690   0   22          plans    NNS         (VP(VP*          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   23             to     TO          (S(VP*          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   24        examine     VB            (VP*     examine  01   1   -          *        *            *      (V*)       *   -
nw/wsj/06/wsj_0690   0   25            Dr.    NNP         (NP(NP*          -    -   -   -          *        *            *   (ARG1*        *   -
nw/wsj/06/wsj_0690   0   26       Toseland    NNP               *          -    -   -   -    (PERSON)       *            *        *        *   -
nw/wsj/06/wsj_0690   0   27             's    POS               *)         -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   28       evidence     NN           *)))))         -    -   -   -          *        *            *        *)       *   -
nw/wsj/06/wsj_0690   0   29            and     CC               *          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   30             is    VBZ            (VP*          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   31    considering    VBG            (VP*    consider  01   -   -          *        *            *        *      (V*)  -
nw/wsj/06/wsj_0690   0   32            its   PRP$         (NP(NP*          -    -   -   -          *        *            *        *   (ARG1*   -
nw/wsj/06/wsj_0690   0   33            own     JJ               *          -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   34          study     NN               *)         -    -   -   -          *        *            *        *        *   -
nw/wsj/06/wsj_0690   0   35           here     RB   (ADVP*))))))))         -    -   -   -          *        *            *)       *        *)  -
nw/wsj/06/wsj_0690   0   36              .      .              *))         -    -   -   -          *        *            *        *        *   -

nw/wsj/06/wsj_0690   0    0             Dr.   NNP                 (TOP(S(NP(NP*          -    -   -   -          *   (ARG0*            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0    1        Toseland   NNP                             *)         -    -   -   -    (PERSON)       *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0    2               ,     ,                             *          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0    3               a    DT                          (NP*          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0    4    toxicologist    NN                             *)         -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0    5               ,     ,                             *)         -    -   -   -          *        *)           *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0    6            said   VBD                          (VP*         say  01   -   -          *      (V*)           *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0    7              he   PRP                   (SBAR(S(NP*)         -    -   -   -          *   (ARG1*       (ARG0*)       *             *        *        *             *   -
nw/wsj/06/wsj_0690   0    8             was   VBD                          (VP*          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0    9       preparing   VBG                          (VP*     prepare  01   -   -          *        *          (V*)       *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   10              an    DT                          (NP*          -    -   -   -          *        *       (ARG1*   (ARG0*             *        *        *             *   -
nw/wsj/06/wsj_0690   0   11         article    NN                             *)         -    -   -   -          *        *            *)       *)            *        *        *             *   -
nw/wsj/06/wsj_0690   0   12             for    IN                          (PP*          -    -   -   -          *        *       (ARG3*        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   13               a    DT                          (NP*          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   14         British    JJ                             *          -    -   -   -      (NORP)       *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   15        forensic    JJ                             *          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   16         medical    JJ                             *          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   17         journal    NN                            *))         -    -   -   -          *        *            *)       *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   18         raising   VBG                        (S(VP*       raise  01   -   -          *        *   (ARGM-PRD*      (V*)            *        *        *             *   -
nw/wsj/06/wsj_0690   0   19             the    DT                          (NP*          -    -   -   -          *        *            *   (ARG1*             *        *        *             *   -
nw/wsj/06/wsj_0690   0   20     possibility    NN                             *          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   21            that    IN                        (SBAR*          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   22             the    DT                        (S(NP*          -    -   -   -          *        *            *        *        (ARG1*        *        *             *   -
nw/wsj/06/wsj_0690   0   23          deaths   NNS                             *)         -    -   -   -          *        *            *        *             *)       *        *             *   -
nw/wsj/06/wsj_0690   0   24             may    MD                          (VP*          -    -   -   -          *        *            *        *    (ARGM-MOD*)       *        *             *   -
nw/wsj/06/wsj_0690   0   25            have    VB                          (VP*          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   26        occurred   VBN                          (VP*       occur  01   -   -          *        *            *        *           (V*)       *        *             *   -
nw/wsj/06/wsj_0690   0   27           after    IN                        (SBAR*          -    -   -   -          *        *            *        *    (ARGM-TMP*        *        *             *   -
nw/wsj/06/wsj_0690   0   28           human    JJ                        (S(NP*          -    -   -   -          *        *            *        *             *   (ARG0*        *             *   -
nw/wsj/06/wsj_0690   0   29         insulin    NN                             *)         -    -   -   -          *        *            *        *             *        *)       *             *   -
nw/wsj/06/wsj_0690   0   30         blunted   VBD                          (VP*       blunt  01   1   -          *        *            *        *             *      (V*)       *             *   -
nw/wsj/06/wsj_0690   0   31        critical    JJ                       (NP(NP*          -    -   -   -          *        *            *        *             *   (ARG1*   (ARG0*             *   -
nw/wsj/06/wsj_0690   0   32         warning    NN                             *          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   33           signs   NNS                             *)         -    -   -   -          *        *            *        *             *        *        *)            *   -
nw/wsj/06/wsj_0690   0   34      indicating   VBG                          (VP*    indicate  01   -   -          *        *            *        *             *        *      (V*)            *   -
nw/wsj/06/wsj_0690   0   35    hypoglycemia    NN                    (NP(NP(NP*)         -    -   -   -          *        *            *        *             *        *   (ARG1*        (ARG0*   -
nw/wsj/06/wsj_0690   0   36               ,     ,                             *          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   37              or    CC                             *          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   38             low    JJ                          (NP*          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   39           blood    NN                             *          -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   40           sugar    NN                             *)         -    -   -   -          *        *            *        *             *        *        *             *   -
nw/wsj/06/wsj_0690   0   41               ,     ,                             *)         -    -   -   -          *        *            *        *             *        *        *             *)  -
nw/wsj/06/wsj_0690   0   42           which   WDT                   (SBAR(WHNP*)         -    -   -   -          *        *            *        *             *        *        *      (R-ARG0*)  -
nw/wsj/06/wsj_0690   0   43             can    MD                        (S(VP*          -    -   -   -          *        *            *        *             *        *        *    (ARGM-MOD*)  -
nw/wsj/06/wsj_0690   0   44            kill    VB                          (VP*        kill  01   -   -          *        *            *        *             *        *        *           (V*)  -
nw/wsj/06/wsj_0690   0   45       diabetics   NNS   (NP*))))))))))))))))))))))))         -    -   -   -          *        *)           *)       *)            *)       *)       *)       (ARG1*)  -
nw/wsj/06/wsj_0690   0   46               .     .                            *))         -    -   -   -          *        *            *        *             *        *        *             *   -

nw/wsj/06/wsj_0690   0    0             The    DT  (TOP(S(NP(NP*         -    -   -   -   *   (ARG2*   -
nw/wsj/06/wsj_0690   0    1           usual    JJ              *         -    -   -   -   *        *   -
nw/wsj/06/wsj_0690   0    2         warning    NN              *         -    -   -   -   *        *   -
nw/wsj/06/wsj_0690   0    3           signs   NNS              *)        -    -   -   -   *        *   -
nw/wsj/06/wsj_0690   0    4              of    IN           (PP*         -    -   -   -   *        *   -
nw/wsj/06/wsj_0690   0    5    hypoglycemia    NN         (NP*)))        -    -   -   -   *        *)  -
nw/wsj/06/wsj_0690   0    6         include   VBP           (VP*    include  01   -   -   *      (V*)  -
nw/wsj/06/wsj_0690   0    7        sweating    NN           (NP*         -    -   -   -   *   (ARG1*   -
nw/wsj/06/wsj_0690   0    8               ,     ,              *         -    -   -   -   *        *   -
nw/wsj/06/wsj_0690   0    9         anxiety    NN              *         -    -   -   -   *        *   -
nw/wsj/06/wsj_0690   0   10             and    CC              *         -    -   -   -   *        *   -
nw/wsj/06/wsj_0690   0   11          cramps   NNS             *))        -    -   -   -   *        *)  -
nw/wsj/06/wsj_0690   0   12               .     .             *))        -    -   -   -   *        *   -

nw/wsj/06/wsj_0690   0    0         With     IN  (TOP(S(PP*         -    -   -   -   *             *    (ARGM-MNR*         *   -
nw/wsj/06/wsj_0690   0    1       proper     JJ        (NP*         -    -   -   -   *    (ARGM-MNR*)            *         *   -
nw/wsj/06/wsj_0690   0    2      warning     NN          *))   warning  01   1   -   *           (V*)            *)        *   -
nw/wsj/06/wsj_0690   0    3            ,      ,           *         -    -   -   -   *             *             *         *   -
nw/wsj/06/wsj_0690   0    4    diabetics    NNS        (NP*)        -    -   -   -   *             *        (ARG0*)   (ARG0*)  -
nw/wsj/06/wsj_0690   0    5          can     MD        (VP*         -    -   -   -   *             *    (ARGM-MOD*)        *   -
nw/wsj/06/wsj_0690   0    6       easily     RB      (ADVP*)        -    -   -   -   *             *    (ARGM-MNR*)        *   -
nw/wsj/06/wsj_0690   0    7        raise     VB        (VP*      raise  01   -   -   *             *           (V*)        *   -
nw/wsj/06/wsj_0690   0    8        their   PRP$        (NP*         -    -   -   -   *             *        (ARG1*         *   -
nw/wsj/06/wsj_0690   0    9        blood     NN           *         -    -   -   -   *             *             *         *   -
nw/wsj/06/wsj_0690   0   10        sugar     NN           *)        -    -   -   -   *             *             *)        *   -
nw/wsj/06/wsj_0690   0   11           to     IN        (PP*         -    -   -   -   *             *        (ARG4*         *   -
nw/wsj/06/wsj_0690   0   12         safe     JJ        (NP*         -    -   -   -   *             *             *         *   -
nw/wsj/06/wsj_0690   0   13       levels    NNS          *))        -    -   -   -   *             *             *)        *   -
nw/wsj/06/wsj_0690   0   14           by     IN        (PP*         -    -   -   -   *             *    (ARGM-MNR*         *   -
nw/wsj/06/wsj_0690   0   15       eating    VBG      (S(VP*        eat  01   -   -   *             *             *       (V*)  -
nw/wsj/06/wsj_0690   0   16        sugar     NN     (NP(NP*)        -    -   -   -   *             *             *    (ARG1*   -
nw/wsj/06/wsj_0690   0   17           or     CC           *         -    -   -   -   *             *             *         *   -
nw/wsj/06/wsj_0690   0   18       sugary     JJ        (NP*         -    -   -   -   *             *             *         *   -
nw/wsj/06/wsj_0690   0   19         food     NN     *)))))))        -    -   -   -   *             *             *)        *)  -
nw/wsj/06/wsj_0690   0   20            .      .          *))        -    -   -   -   *             *             *         *   -

nw/wsj/06/wsj_0690   0    0              ``    ``         (TOP(S*      -    -   -   -          *             *             *        *   -
nw/wsj/06/wsj_0690   0    1             The    DT          (S(NP*      -    -   -   -          *        (ARG0*             *   (ARG1*   -
nw/wsj/06/wsj_0690   0    2       anecdotal    JJ               *      -    -   -   -          *             *             *        *   -
nw/wsj/06/wsj_0690   0    3            data    NN               *)     -    -   -   -          *             *)            *        *   -
nw/wsj/06/wsj_0690   0    4       certainly    RB          (ADVP*)     -    -   -   -          *    (ARGM-ADV*)            *        *   -
nw/wsj/06/wsj_0690   0    5           shows   VBZ            (VP*    show  01   -   -          *           (V*)            *        *   -
nw/wsj/06/wsj_0690   0    6            that    IN          (SBAR*      -    -   -   -          *        (ARG1*             *        *   -
nw/wsj/06/wsj_0690   0    7            some    DT       (S(NP(NP*)     -    -   -   -          *             *        (ARG1*        *   -
nw/wsj/06/wsj_0690   0    8              of    IN            (PP*      -    -   -   -          *             *             *        *   -
nw/wsj/06/wsj_0690   0    9             the    DT            (NP*      -    -   -   -          *             *             *        *   -
nw/wsj/06/wsj_0690   0   10          people   NNS             *)))     -    -   -   -          *             *             *)       *   -
nw/wsj/06/wsj_0690   0   11            were   VBD            (VP*      be  01   -   -          *             *           (V*)       *   -
nw/wsj/06/wsj_0690   0   12             not    RB               *      -    -   -   -          *             *    (ARGM-NEG*)       *   -
nw/wsj/06/wsj_0690   0   13           aware    JJ          (ADJP*      -    -   -   -          *             *        (ARG2*        *   -
nw/wsj/06/wsj_0690   0   14              of    IN            (PP*      -    -   -   -          *             *             *        *   -
nw/wsj/06/wsj_0690   0   15             the    DT         (NP(NP*      -    -   -   -          *             *             *        *   -
nw/wsj/06/wsj_0690   0   16           rapid    JJ               *      -    -   -   -          *             *             *        *   -
nw/wsj/06/wsj_0690   0   17           onset    NN               *)     -    -   -   -          *             *             *        *   -
nw/wsj/06/wsj_0690   0   18              of    IN            (PP*      -    -   -   -          *             *             *        *   -
nw/wsj/06/wsj_0690   0   19    hypoglycemia    NN   (NP*))))))))))     -    -   -   -          *             *)            *)       *)  -
nw/wsj/06/wsj_0690   0   20               ,     ,               *      -    -   -   -          *             *             *        *   -
nw/wsj/06/wsj_0690   0   21              ''    ''               *      -    -   -   -          *             *             *        *   -
nw/wsj/06/wsj_0690   0   22             Dr.   NNP            (NP*      -    -   -   -          *             *             *   (ARG0*   -
nw/wsj/06/wsj_0690   0   23        Toseland   NNP               *)     -    -   -   -    (PERSON)            *             *        *)  -
nw/wsj/06/wsj_0690   0   24            said   VBD            (VP*)    say  01   -   -          *             *             *      (V*)  -
nw/wsj/06/wsj_0690   0   25               .     .              *))     -    -   -   -          *             *             *        *   -

nw/wsj/06/wsj_0690   0    0              At    IN      (TOP(S(PP*      -    -   -   -            *   (ARGM-LOC*            *            *   -
nw/wsj/06/wsj_0690   0    1             the    DT         (NP(NP*      -    -   -   -        (ORG*            *            *            *   -
nw/wsj/06/wsj_0690   0    2            U.S.   NNP               *      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0    3        National   NNP               *      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0    4      Institutes   NNP               *)     -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0    5              of    IN            (PP*      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0    6          Health   NNP         (NP*))))     -    -   -   -            *)           *)           *            *   -
nw/wsj/06/wsj_0690   0    7               ,     ,               *      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0    8             Dr.   NNP         (NP(NP*      -    -   -   -            *       (ARG0*            *            *   -
nw/wsj/06/wsj_0690   0    9          Robert   NNP               *      -    -   -   -     (PERSON*            *            *            *   -
nw/wsj/06/wsj_0690   0   10              E.   NNP               *      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   11       Silverman   NNP               *)     -    -   -   -            *)           *            *            *   -
nw/wsj/06/wsj_0690   0   12               ,     ,               *      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   13           chief    NN         (NP(NP*)     -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   14              of    IN            (PP*      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   15             the    DT            (NP*      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   16        diabetes    NN               *      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   17         program    NN               *      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   18          branch    NN             *)))     -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   19               ,     ,               *)     -    -   -   -            *            *)           *            *   -
nw/wsj/06/wsj_0690   0   20            said   VBD            (VP*     say  01   -   -            *          (V*)           *            *   -
nw/wsj/06/wsj_0690   0   21              no    DT  (SBAR(S(NP(NP*      -    -   -   -            *       (ARG1*       (ARG1*            *   -
nw/wsj/06/wsj_0690   0   22        evidence    NN               *)     -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   23              of    IN            (PP*      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   24      unexpected    JJ         (NP(NP*      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   25          deaths   NNS               *)     -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   26            from    IN            (PP*      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   27    hypoglycemia    NN        (NP*)))))     -    -   -   -            *            *            *)           *   -
nw/wsj/06/wsj_0690   0   28             had   VBD            (VP*      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   29           shown   VBN            (VP*    show  02   -   -            *            *          (V*)           *   -
nw/wsj/06/wsj_0690   0   30              up    RP           (PRT*)     -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   31              in    IN            (PP*      -    -   -   -            *            *   (ARGM-LOC*            *   -
nw/wsj/06/wsj_0690   0   32               a    DT      (NP(NP(NP*      -    -   -   -            *            *            *       (ARG1*   -
nw/wsj/06/wsj_0690   0   33           study    NN               *)     -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   34              of    IN            (PP*      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   35          1,500     CD            (NP*      -    -   -   -    (CARDINAL)           *            *            *   -
nw/wsj/06/wsj_0690   0   36       diabetics   NNS             *)))     -    -   -   -            *            *            *            *)  -
nw/wsj/06/wsj_0690   0   37            that   WDT     (SBAR(WHNP*)     -    -   -   -            *            *            *     (R-ARG1*)  -
nw/wsj/06/wsj_0690   0   38             has   VBZ          (S(VP*      -    -   -   -            *            *            *            *   -
nw/wsj/06/wsj_0690   0   39            been   VBN            (VP*      be  01   -   -            *            *            *          (V*)  -
nw/wsj/06/wsj_0690   0   40           under    IN            (PP*      -    -   -   -            *            *            *       (ARG2*   -
nw/wsj/06/wsj_0690   0   41             way    NN           (NP*))     -    -   -   -            *            *            *            *)  -
nw/wsj/06/wsj_0690   0   42              at    IN            (PP*      -    -   -   -            *            *            *   (ARGM-LOC*   -
nw/wsj/06/wsj_0690   0   43             NIH   NNP           (NP*))     -    -   -   -         (ORG)           *            *            *)  -
nw/wsj/06/wsj_0690   0   44             for    IN            (PP*      -    -   -   -            *            *            *   (ARGM-TMP*   -
nw/wsj/06/wsj_0690   0   45            five    CD            (NP*      -    -   -   -       (DATE*            *            *            *   -
nw/wsj/06/wsj_0690   0   46           years   NNS   *)))))))))))))     -    -   -   -            *)           *)           *)           *)  -
nw/wsj/06/wsj_0690   0   47               .     .              *))     -    -   -   -            *            *            *            *   -

nw/wsj/06/wsj_0690   0    0         However    RB     (TOP(S(ADVP*)        -    -   -   -   *    (ARGM-DIS*)        *             *         *   -
nw/wsj/06/wsj_0690   0    1               ,     ,                *         -    -   -   -   *             *         *             *         *   -
nw/wsj/06/wsj_0690   0    2              he   PRP             (NP*)        -    -   -   -   *        (ARG0*)        *             *         *   -
nw/wsj/06/wsj_0690   0    3            said   VBD             (VP*        say  01   -   -   *           (V*)        *             *         *   -
nw/wsj/06/wsj_0690   0    4       officials   NNS   (SBAR(S(NP(NP*)        -    -   -   -   *        (ARG1*    (ARG0*)       (ARG0*         *   -
nw/wsj/06/wsj_0690   0    5      conducting   VBG             (VP*    conduct  01   -   -   *             *       (V*)            *         *   -
nw/wsj/06/wsj_0690   0    6             the    DT             (NP*         -    -   -   -   *             *    (ARG1*             *         *   -
nw/wsj/06/wsj_0690   0    7           study    NN              *)))        -    -   -   -   *             *         *)            *)        *   -
nw/wsj/06/wsj_0690   0    8             had   VBD             (VP*         -    -   -   -   *             *         *             *         *   -
nw/wsj/06/wsj_0690   0    9             n't    RB                *         -    -   -   -   *             *         *    (ARGM-NEG*)        *   -
nw/wsj/06/wsj_0690   0   10            been   VBN             (VP*         -    -   -   -   *             *         *             *         *   -
nw/wsj/06/wsj_0690   0   11         looking   VBG             (VP*       look  01   -   -   *             *         *           (V*)        *   -
nw/wsj/06/wsj_0690   0   12             for    IN             (PP*         -    -   -   -   *             *         *        (ARG1*         *   -
nw/wsj/06/wsj_0690   0   13           signs   NNS          (NP(NP*)        -    -   -   -   *             *         *             *         *   -
nw/wsj/06/wsj_0690   0   14              of    IN             (PP*         -    -   -   -   *             *         *             *         *   -
nw/wsj/06/wsj_0690   0   15        problems   NNS          (NP(NP*)        -    -   -   -   *             *         *             *    (ARG1*)  -
nw/wsj/06/wsj_0690   0   16         related   VBN           (ADJP*     relate  01   -   -   *             *         *             *       (V*)  -
nw/wsj/06/wsj_0690   0   17              to    IN             (PP*         -    -   -   -   *             *         *             *    (ARG2*   -
nw/wsj/06/wsj_0690   0   18    hypoglycemia    NN             (NP*         -    -   -   -   *             *         *             *         *   -
nw/wsj/06/wsj_0690   0   19     unawareness    NN    *)))))))))))))        -    -   -   -   *             *)        *             *)        *)  -
nw/wsj/06/wsj_0690   0   20               .     .               *))        -    -   -   -   *             *         *             *         *   -

nw/wsj/06/wsj_0690   0    0            ``    ``  (TOP(S*         -    -   -   -   *             *         *   -
nw/wsj/06/wsj_0690   0    1            We   PRP   (S(NP*)        -    -   -   -   *        (ARG0*)   (ARG1*   -
nw/wsj/06/wsj_0690   0    2           are   VBP     (VP*         -    -   -   -   *             *         *   -
nw/wsj/06/wsj_0690   0    3           now    RB   (ADVP*)        -    -   -   -   *    (ARGM-TMP*)        *   -
nw/wsj/06/wsj_0690   0    4    monitoring   VBG     (VP*    monitor  01   1   -   *           (V*)        *   -
nw/wsj/06/wsj_0690   0    5           for    IN     (PP*         -    -   -   -   *        (ARG2*         *   -
nw/wsj/06/wsj_0690   0    6            it   PRP    (NP*))        -    -   -   -   *             *)        *   -
nw/wsj/06/wsj_0690   0    7          much    RB   (ADVP*         -    -   -   -   *    (ARGM-MNR*         *   -
nw/wsj/06/wsj_0690   0    8          more   RBR        *         -    -   -   -   *             *         *   -
nw/wsj/06/wsj_0690   0    9       closely    RB     *))))        -    -   -   -   *             *)        *)  -
nw/wsj/06/wsj_0690   0   10             ,     ,        *         -    -   -   -   *             *         *   -
nw/wsj/06/wsj_0690   0   11            ''    ''        *         -    -   -   -   *             *         *   -
nw/wsj/06/wsj_0690   0   12            he   PRP     (NP*)        -    -   -   -   *             *    (ARG0*)  -
nw/wsj/06/wsj_0690   0   13          said   VBD     (VP*)       say  01   -   -   *             *       (V*)  -
nw/wsj/06/wsj_0690   0   14             .     .       *))        -    -   -   -   *             *         *   -

nw/wsj/06/wsj_0690   0    0             ``    ``           (TOP(S*       -    -   -   -          *         *        *            *        *   -
nw/wsj/06/wsj_0690   0    1             We   PRP            (S(NP*)      -    -   -   -          *    (ARG0*)       *            *   (ARG1*   -
nw/wsj/06/wsj_0690   0    2             do   VBP              (VP*       -    -   -   -          *         *        *            *        *   -
nw/wsj/06/wsj_0690   0    3           know    VB              (VP*     know  01   1   -          *       (V*)       *            *        *   -
nw/wsj/06/wsj_0690   0    4          there    EX       (SBAR(S(NP*)      -    -   -   -          *    (ARG1*        *            *        *   -
nw/wsj/06/wsj_0690   0    5            are   VBP              (VP*       be  02   -   -          *         *      (V*)           *        *   -
nw/wsj/06/wsj_0690   0    6         slight    JJ           (NP(NP*       -    -   -   -          *         *   (ARG1*            *        *   -
nw/wsj/06/wsj_0690   0    7    differences   NNS                 *)      -    -   -   -          *         *        *            *        *   -
nw/wsj/06/wsj_0690   0    8             in    IN              (PP*       -    -   -   -          *         *        *            *        *   -
nw/wsj/06/wsj_0690   0    9            the    DT           (NP(NP*       -    -   -   -          *         *        *   (ARGM-MNR*        *   -
nw/wsj/06/wsj_0690   0   10            way    NN                 *)      -    -   -   -          *         *        *            *)       *   -
nw/wsj/06/wsj_0690   0   11          human    JJ  (SBAR(S(NP(ADJP*       -    -   -   -          *         *        *       (ARG0*        *   -
nw/wsj/06/wsj_0690   0   12            and    CC                 *       -    -   -   -          *         *        *            *        *   -
nw/wsj/06/wsj_0690   0   13         animal    JJ                 *)      -    -   -   -          *         *        *            *        *   -
nw/wsj/06/wsj_0690   0   14       insulins   NNS                 *)      -    -   -   -          *         *        *            *)       *   -
nw/wsj/06/wsj_0690   0   15          drive   VBP              (VP*    drive  02   -   -          *         *        *          (V*)       *   -
nw/wsj/06/wsj_0690   0   16           down    RP             (PRT*)      -    -   -   -          *         *        *       (ARG2*)       *   -
nw/wsj/06/wsj_0690   0   17          blood    NN              (NP*       -    -   -   -          *         *        *       (ARG1*        *   -
nw/wsj/06/wsj_0690   0   18          sugar    NN     *)))))))))))))      -    -   -   -          *         *)       *)           *)       *)  -
nw/wsj/06/wsj_0690   0   19              ,     ,                 *       -    -   -   -          *         *        *            *        *   -
nw/wsj/06/wsj_0690   0   20             ''    ''                 *       -    -   -   -          *         *        *            *        *   -
nw/wsj/06/wsj_0690   0   21            Dr.   NNP              (NP*       -    -   -   -          *         *        *            *   (ARG0*   -
nw/wsj/06/wsj_0690   0   22          Sobel   NNP                 *)      -    -   -   -    (PERSON)        *        *            *        *)  -
nw/wsj/06/wsj_0690   0   23           said   VBD              (VP*)     say  01   -   -          *         *        *            *      (V*)  -
nw/wsj/06/wsj_0690   0   24              .     .                *))      -    -   -   -          *         *        *            *        *   -

nw/wsj/06/wsj_0690   0    0         The     DT  (TOP(S(S(NP*       -    -   -   -   *        (ARG2*             *        (ARG0*         *   -
nw/wsj/06/wsj_0690   0    1       human     NN        (ADJP*       -    -   -   -   *             *             *             *         *   -
nw/wsj/06/wsj_0690   0    2          -    HYPH             *       -    -   -   -   *             *             *             *         *   -
nw/wsj/06/wsj_0690   0    3       based    VBN             *)      -    -   -   -   *             *             *             *         *   -
nw/wsj/06/wsj_0690   0    4        drug     NN             *)      -    -   -   -   *             *)            *             *)        *   -
nw/wsj/06/wsj_0690   0    5      starts    VBZ       (VP(VP*    start  01   -   -   *           (V*)            *             *         *   -
nw/wsj/06/wsj_0690   0    6         the     DT          (NP*       -    -   -   -   *        (ARG1*        (ARG1*             *         *   -
nw/wsj/06/wsj_0690   0    7       blood     NN             *       -    -   -   -   *             *             *             *         *   -
nw/wsj/06/wsj_0690   0    8       sugar     NN             *       -    -   -   -   *             *             *)            *         *   -
nw/wsj/06/wsj_0690   0    9    dropping    VBG             *)    drop  01   -   -   *             *)          (V*)            *         *   -
nw/wsj/06/wsj_0690   0   10      sooner    RBR       (ADVP*))      -    -   -   -   *    (ARGM-TMP*)   (ARGM-TMP*)            *         *   -
nw/wsj/06/wsj_0690   0   11         and     CC             *       -    -   -   -   *             *             *             *         *   -
nw/wsj/06/wsj_0690   0   12      drives    VBZ          (VP*    drive  02   -   -   *             *             *           (V*)        *   -
nw/wsj/06/wsj_0690   0   13          it    PRP          (NP*)      -    -   -   -   *             *             *        (ARG1*)        *   -
nw/wsj/06/wsj_0690   0   14        down     RP         (PRT*)      -    -   -   -   *             *             *        (ARG2*)        *   -
nw/wsj/06/wsj_0690   0   15      faster    RBR     (ADVP*))))      -    -   -   -   *             *             *    (ARGM-MNR*)        *   -
nw/wsj/06/wsj_0690   0   16           ,      ,             *       -    -   -   -   *             *             *             *         *   -
nw/wsj/06/wsj_0690   0   17          he    PRP          (NP*)      -    -   -   -   *             *             *             *    (ARG0*)  -
nw/wsj/06/wsj_0690   0   18        said    VBD          (VP*)     say  01   -   -   *             *             *             *       (V*)  -
nw/wsj/06/wsj_0690   0   19           .      .            *))      -    -   -   -   *             *             *             *         *   -

nw/wsj/06/wsj_0690   0    0             ``    ``       (TOP(S*         -    -   -   -          *             *        *        *        *   -
nw/wsj/06/wsj_0690   0    1            But    CC           (S*         -    -   -   -          *    (ARGM-NEG*)       *        *   (ARG1*   -
nw/wsj/06/wsj_0690   0    2             we   PRP          (NP*)        -    -   -   -          *        (ARG0*)       *        *        *   -
nw/wsj/06/wsj_0690   0    3             do   VBP          (VP*         -    -   -   -          *             *        *        *        *   -
nw/wsj/06/wsj_0690   0    4            n't    RB             *         -    -   -   -          *    (ARGM-NEG*)       *        *        *   -
nw/wsj/06/wsj_0690   0    5        believe    VB          (VP*    believe  01   -   -          *           (V*)       *        *        *   -
nw/wsj/06/wsj_0690   0    6          there    EX   (SBAR(S(NP*)        -    -   -   -          *        (ARG1*        *        *        *   -
nw/wsj/06/wsj_0690   0    7             is   VBZ          (VP*         be  02   -   -          *             *      (V*)       *        *   -
nw/wsj/06/wsj_0690   0    8         enough    JJ        (ADJP*         -    -   -   -          *             *   (ARG1*        *        *   -
nw/wsj/06/wsj_0690   0    9             of    IN          (PP*         -    -   -   -          *             *        *        *        *   -
nw/wsj/06/wsj_0690   0   10              a    DT          (NP*         -    -   -   -          *             *        *        *        *   -
nw/wsj/06/wsj_0690   0   11     difference    NN            *))        -    -   -   -          *             *        *        *        *   -
nw/wsj/06/wsj_0690   0   12             to    TO        (S(VP*         -    -   -   -          *             *        *        *        *   -
nw/wsj/06/wsj_0690   0   13             be    VB          (VP*         be  01   -   -          *             *        *      (V*)       *   -
nw/wsj/06/wsj_0690   0   14     clinically    RB        (ADJP*         -    -   -   -          *             *        *   (ARG2*        *   -
nw/wsj/06/wsj_0690   0   15    significant    JJ   *)))))))))))        -    -   -   -          *             *)       *)       *)       *)  -
nw/wsj/06/wsj_0690   0   16              ,     ,             *         -    -   -   -          *             *        *        *        *   -
nw/wsj/06/wsj_0690   0   17             ''    ''             *         -    -   -   -          *             *        *        *        *   -
nw/wsj/06/wsj_0690   0   18            Dr.   NNP          (NP*         -    -   -   -          *             *        *        *   (ARG0*   -
nw/wsj/06/wsj_0690   0   19          Sobel   NNP             *)        -    -   -   -    (PERSON)            *        *        *        *)  -
nw/wsj/06/wsj_0690   0   20           said   VBD          (VP*)       say  01   -   -          *             *        *        *      (V*)  -
nw/wsj/06/wsj_0690   0   21              .     .            *))        -    -   -   -          *             *        *        *        *   -

nw/wsj/06/wsj_0690   0    0       Reports   NNS   (TOP(S(NP(NP*)        -    -   -   -          *       (ARG0*   -
nw/wsj/06/wsj_0690   0    1            of    IN            (PP*         -    -   -   -          *            *   -
nw/wsj/06/wsj_0690   0    2           Dr.   NNP         (NP(NP*         -    -   -   -          *            *   -
nw/wsj/06/wsj_0690   0    3      Toseland   NNP               *         -    -   -   -    (PERSON)           *   -
nw/wsj/06/wsj_0690   0    4            's   POS               *)        -    -   -   -          *            *   -
nw/wsj/06/wsj_0690   0    5      findings   NNS              *))        -    -   -   -          *            *   -
nw/wsj/06/wsj_0690   0    6            in    IN            (PP*         -    -   -   -          *            *   -
nw/wsj/06/wsj_0690   0    7           the    DT            (NP*         -    -   -   -          *            *   -
nw/wsj/06/wsj_0690   0    8       British    JJ               *         -    -   -   -      (NORP)           *   -
nw/wsj/06/wsj_0690   0    9         press    NN             *)))        -    -   -   -          *            *)  -
nw/wsj/06/wsj_0690   0   10          have   VBP            (VP*         -    -   -   -          *            *   -
nw/wsj/06/wsj_0690   0   11     triggered   VBN            (VP*    trigger  01   1   -          *          (V*)  -
nw/wsj/06/wsj_0690   0   12    widespread    JJ            (NP*         -    -   -   -          *       (ARG1*   -
nw/wsj/06/wsj_0690   0   13       concern    NN               *)        -    -   -   -          *            *)  -
nw/wsj/06/wsj_0690   0   14         among    IN            (PP*         -    -   -   -          *   (ARGM-LOC*   -
nw/wsj/06/wsj_0690   0   15     diabetics   NNS         (NP(NP*)        -    -   -   -          *            *   -
nw/wsj/06/wsj_0690   0   16         there    RB      (ADVP*)))))        -    -   -   -          *            *)  -
nw/wsj/06/wsj_0690   0   17             .     .              *))        -    -   -   -          *            *   -

nw/wsj/06/wsj_0690   0    0           Both    DT    (TOP(S(NP*            -    -   -   -          *        (ARG0*         *        *   -
nw/wsj/06/wsj_0690   0    1            the    DT          (NP*            -    -   -   -      (ORG*             *         *        *   -
nw/wsj/06/wsj_0690   0    2        British   NNP             *            -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0    3       Diabetic   NNP             *            -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0    4    Association   NNP             *)           -    -   -   -          *)            *         *        *   -
nw/wsj/06/wsj_0690   0    5            and    CC             *            -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0    6            the    DT       (NP(NP*            -    -   -   -      (ORG*             *         *        *   -
nw/wsj/06/wsj_0690   0    7      Committee   NNP             *)           -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0    8             on    IN          (PP*            -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0    9         Safety   NNP       (NP(NP*)           -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0   10             in    IN          (PP*            -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0   11      Medicines   NNP       (NP*))))           -    -   -   -          *)            *         *        *   -
nw/wsj/06/wsj_0690   0   12            --      :             *            -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0   13        Britain   NNP    (NP(NP(NP*            -    -   -   -       (GPE)            *         *        *   -
nw/wsj/06/wsj_0690   0   14             's   POS             *)           -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0   15     equivalent    NN             *)   equivalent   -   1   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0   16             of    IN          (PP*            -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0   17            the    DT          (NP*            -    -   -   -      (ORG*             *         *        *   -
nw/wsj/06/wsj_0690   0   18           U.S.   NNP             *            -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0   19            FDA   NNP           *)))           -    -   -   -          *)            *         *        *   -
nw/wsj/06/wsj_0690   0   20            --      :            *))           -    -   -   -          *             *)        *        *   -
nw/wsj/06/wsj_0690   0   21       recently    RB        (ADVP*)           -    -   -   -          *    (ARGM-TMP*)        *        *   -
nw/wsj/06/wsj_0690   0   22         issued   VBD          (VP*         issue  01   -   -          *           (V*)        *        *   -
nw/wsj/06/wsj_0690   0   23     statements   NNS       (NP(NP*)           -    -   -   -          *        (ARG1*    (ARG0*)       *   -
nw/wsj/06/wsj_0690   0   24         noting   VBG          (VP*          note  01   -   -          *             *       (V*)       *   -
nw/wsj/06/wsj_0690   0   25            the    DT       (NP(NP*            -    -   -   -          *             *    (ARG1*        *   -
nw/wsj/06/wsj_0690   0   26           lack    NN             *)           -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0   27             of    IN          (PP*            -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0   28           hard    JJ       (NP(NP*            -    -   -   -          *             *         *   (ARG0*   -
nw/wsj/06/wsj_0690   0   29     scientific    JJ             *            -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0   30       evidence    NN             *)           -    -   -   -          *             *         *        *)  -
nw/wsj/06/wsj_0690   0   31             to    TO   (SBAR(S(VP*            -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0   32        support    VB          (VP*       support  01   -   -          *             *         *      (V*)  -
nw/wsj/06/wsj_0690   0   33            Dr.   NNP       (NP(NP*            -    -   -   -          *             *         *   (ARG1*   -
nw/wsj/06/wsj_0690   0   34       Toseland   NNP             *            -    -   -   -    (PERSON)            *         *        *   -
nw/wsj/06/wsj_0690   0   35             's   POS             *)           -    -   -   -          *             *         *        *   -
nw/wsj/06/wsj_0690   0   36       findings   NNS   *)))))))))))           -    -   -   -          *             *)        *)       *)  -
nw/wsj/06/wsj_0690   0   37              .     .            *))           -    -   -   -          *             *         *        *   -

nw/wsj/06/wsj_0690   0    0             On    IN  (TOP(S(PP*           -    -   -   -            *   (ARGM-TMP*        *             *   -
nw/wsj/06/wsj_0690   0    1         Friday   NNP       (NP*))          -    -   -   -        (DATE)           *)       *             *   -
nw/wsj/06/wsj_0690   0    2              ,     ,           *           -    -   -   -            *            *        *             *   -
nw/wsj/06/wsj_0690   0    3            the    DT        (NP*           -    -   -   -        (ORG*       (ARG0*        *             *   -
nw/wsj/06/wsj_0690   0    4       American   NNP           *           -    -   -   -            *            *        *             *   -
nw/wsj/06/wsj_0690   0    5       Diabetes   NNP           *           -    -   -   -            *            *        *             *   -
nw/wsj/06/wsj_0690   0    6    Association   NNP           *)          -    -   -   -            *)           *)       *             *   -
nw/wsj/06/wsj_0690   0    7         issued   VBD        (VP*        issue  01   -   -            *          (V*)       *             *   -
nw/wsj/06/wsj_0690   0    8              a    DT     (NP(NP*           -    -   -   -            *       (ARG1*   (ARG0*             *   -
nw/wsj/06/wsj_0690   0    9        similar    JJ           *           -    -   -   -            *            *        *             *   -
nw/wsj/06/wsj_0690   0   10      statement    NN           *)          -    -   -   -            *            *        *)            *   -
nw/wsj/06/wsj_0690   0   11         urging   VBG        (VP*         urge  01   -   -            *            *      (V*)            *   -
nw/wsj/06/wsj_0690   0   12            the    DT        (NP*           -    -   -   -            *            *   (ARG1*        (ARG0*   -
nw/wsj/06/wsj_0690   0   13            six    CD        (QP*           -    -   -   -   (CARDINAL*            *        *             *   -
nw/wsj/06/wsj_0690   0   14        million    CD           *)          -    -   -   -            *)           *        *             *   -
nw/wsj/06/wsj_0690   0   15           U.S.   NNP           *           -    -   -   -         (GPE)           *        *             *   -
nw/wsj/06/wsj_0690   0   16      diabetics   NNS           *)          -    -   -   -            *            *        *)            *)  -
nw/wsj/06/wsj_0690   0   17            not    RB         (S*           -    -   -   -            *            *   (ARG2*    (ARGM-NEG*)  -
nw/wsj/06/wsj_0690   0   18             to    TO        (VP*           -    -   -   -            *            *        *             *   -
nw/wsj/06/wsj_0690   0   19      overreact    VB        (VP*    overreact  01   1   -            *            *        *           (V*)  -
nw/wsj/06/wsj_0690   0   20             to    IN        (PP*           -    -   -   -            *            *        *        (ARG1*   -
nw/wsj/06/wsj_0690   0   21            the    DT        (NP*           -    -   -   -            *            *        *             *   -
nw/wsj/06/wsj_0690   0   22        British    JJ           *           -    -   -   -        (NORP)           *        *             *   -
nw/wsj/06/wsj_0690   0   23         report    NN    *))))))))          -    -   -   -            *            *)       *)            *)  -
nw/wsj/06/wsj_0690   0   24              .     .          *))          -    -   -   -            *            *        *             *   -

nw/wsj/06/wsj_0690   0    0              ``    ``             (TOP(S*             -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0    1               A    DT           (S(NP(NP*             -    -   -   -        *   (ARG1*           *         *        *   (ARG1*   -
nw/wsj/06/wsj_0690   0    2            loss    NN                   *)            -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0    3              of    IN                (PP*             -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0    4             the    DT             (NP(NP*             -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0    5         warning    NN                   *             -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0    6        symptoms   NNS                   *)            -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0    7              of    IN                (PP*             -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0    8    hypoglycemia    NN            (NP*)))))            -    -   -   -        *        *)          *         *        *        *   -
nw/wsj/06/wsj_0690   0    9              is   VBZ                (VP*             be  01   -   -        *      (V*)          *         *        *        *   -
nw/wsj/06/wsj_0690   0   10               a    DT             (NP(NP*             -    -   -   -        *   (ARG2*      (ARG1*         *        *        *   -
nw/wsj/06/wsj_0690   0   11         complex    JJ                   *             -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0   12         problem    NN                   *)            -    -   -   -        *        *           *)        *        *        *   -
nw/wsj/06/wsj_0690   0   13            that   WDT         (SBAR(WHNP*)            -    -   -   -        *        *    (R-ARG1*)   (ARG1*)       *        *   -
nw/wsj/06/wsj_0690   0   14              is   VBZ              (S(VP*             be  01   -   -        *        *         (V*)        *        *        *   -
nw/wsj/06/wsj_0690   0   15            very    RB              (ADJP*             -    -   -   -        *        *      (ARG2*         *        *        *   -
nw/wsj/06/wsj_0690   0   16        unlikely    JJ                   *             -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0   17              to    TO              (S(VP*             -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0   18              be    VB                (VP*             be  01   -   -        *        *           *       (V*)       *        *   -
nw/wsj/06/wsj_0690   0   19             due    RB              (ADVP*             -    -   -   -        *        *           *    (ARG2*        *        *   -
nw/wsj/06/wsj_0690   0   20          simply    RB           (PP(ADVP*)            -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0   21              to    IN                   *             -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0   22             the    DT          (NP(NP(NP*             -    -   -   -        *        *           *         *   (ARG1*        *   -
nw/wsj/06/wsj_0690   0   23            type    NN                   *)            -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0   24              of    IN                (PP*             -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0   25         insulin    NN              (NP*)))            -    -   -   -        *        *           *         *        *)       *   -
nw/wsj/06/wsj_0690   0   26            used   VBN   (VP*))))))))))))))           use  01   -   -        *        *)          *)        *)     (V*)       *)  -
nw/wsj/06/wsj_0690   0   27               ,     ,                   *             -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0   28              ''    ''                   *             -    -   -   -        *        *           *         *        *        *   -
nw/wsj/06/wsj_0690   0   29             the    DT                (NP*             -    -   -   -        *        *           *         *        *   (ARG0*   -
nw/wsj/06/wsj_0690   0   30        American    JJ                   *             -    -   -   -    (NORP)       *           *         *        *        *   -
nw/wsj/06/wsj_0690   0   31     association    NN                   *)   association   -   1   -        *        *           *         *        *        *)  -
nw/wsj/06/wsj_0690   0   32            said   VBD                (VP*)           say  01   -   -        *        *           *         *        *      (V*)  -
nw/wsj/06/wsj_0690   0   33               .     .                  *))            -    -   -   -        *        *           *         *        *        *   -

nw/wsj/06/wsj_0690   0    0              The     DT    (TOP(S(NP*         -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0    1              FDA    NNP             *)        -    -   -   -    (ORG)           *        *   -
nw/wsj/06/wsj_0690   0    2          already     RB        (ADVP*)        -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0    3         requires    VBZ          (VP*         -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0    4             drug     NN          (NP*         -    -   -   -       *       (ARG0*        *   -
nw/wsj/06/wsj_0690   0    5    manufacturers    NNS             *)        -    -   -   -       *            *)       *   -
nw/wsj/06/wsj_0690   0    6               to     TO        (S(VP*         -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0    7          include     VB          (VP*    include  01   -   -       *          (V*)       *   -
nw/wsj/06/wsj_0690   0    8         warnings    NNS          (NP*)        -    -   -   -       *       (ARG1*)       *   -
nw/wsj/06/wsj_0690   0    9             with     IN          (PP*         -    -   -   -       *   (ARGM-LOC*        *   -
nw/wsj/06/wsj_0690   0   10          insulin     NN          (NP*         -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0   11         products    NNS            *))        -    -   -   -       *            *)       *   -
nw/wsj/06/wsj_0690   0   12             that     IN        (SBAR*         -    -   -   -       *     (C-ARG1*        *   -
nw/wsj/06/wsj_0690   0   13         symptoms    NNS     (S(NP(NP*)        -    -   -   -       *            *   (ARG1*   -
nw/wsj/06/wsj_0690   0   14               of     IN          (PP*         -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0   15     hypoglycemia     NN        (NP*)))        -    -   -   -       *            *        *)  -
nw/wsj/06/wsj_0690   0   16              are    VBP          (VP*         be  01   -   -       *            *      (V*)  -
nw/wsj/06/wsj_0690   0   17             less    RBR   (ADJP(ADJP*         -    -   -   -       *            *   (ARG2*   -
nw/wsj/06/wsj_0690   0   18       pronounced     JJ             *)        -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0   19             with     IN          (PP*         -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0   20            human     JJ          (NP*         -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0   21          insulin     NN            *))        -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0   22             than     IN          (PP*         -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0   23             with     IN          (PP*         -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0   24           animal     NN     (NP(ADJP*         -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0   25               -    HYPH             *         -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0   26            based    VBN             *)        -    -   -   -       *            *        *   -
nw/wsj/06/wsj_0690   0   27         products    NNS   *)))))))))))        -    -   -   -       *            *)       *)  -
nw/wsj/06/wsj_0690   0   28                .      .            *))        -    -   -   -       *            *        *   -

nw/wsj/06/wsj_0690   0    0             Eli    NNP  (TOP(S(NP(NP*          -    -   -   -       (ORG*       (ARG0*        *   -
nw/wsj/06/wsj_0690   0    1           Lilly    NNP              *          -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0    2               &     CC              *          -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0    3             Co.    NNP              *)         -    -   -   -           *)           *        *   -
nw/wsj/06/wsj_0690   0    4               ,      ,              *          -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0    5             the     DT           (NP*          -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0    6    Indianapolis    NNP         (ADJP*          -    -   -   -        (GPE)           *        *   -
nw/wsj/06/wsj_0690   0    7              -    HYPH              *          -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0    8           based    VBN              *)         -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0    9            drug     NN              *          -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0   10    manufacturer     NN              *)         -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0   11               ,      ,              *)         -    -   -   -           *            *)       *   -
nw/wsj/06/wsj_0690   0   12       dominates    VBZ           (VP*    dominate  01   1   -           *          (V*)       *   -
nw/wsj/06/wsj_0690   0   13             the     DT           (NP*          -    -   -   -           *       (ARG1*        *   -
nw/wsj/06/wsj_0690   0   14            U.S.    NNP              *          -    -   -   -        (GPE)           *        *   -
nw/wsj/06/wsj_0690   0   15           human     JJ          (NML*          -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0   16         insulin     NN              *)         -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0   17          market     NN              *)         -    -   -   -           *            *)       *   -
nw/wsj/06/wsj_0690   0   18            with     IN           (PP*          -    -   -   -           *   (ARGM-MNR*        *   -
nw/wsj/06/wsj_0690   0   19             its   PRP$        (NP(NP*          -    -   -   -           *            *   (ARG1*   -
nw/wsj/06/wsj_0690   0   20         product     NN              *)         -    -   -   -           *            *        *)  -
nw/wsj/06/wsj_0690   0   21           known    VBN           (VP*        know  01   2   -           *            *      (V*)  -
nw/wsj/06/wsj_0690   0   22              as     IN           (PP*          -    -   -   -           *            *   (ARG2*   -
nw/wsj/06/wsj_0690   0   23         Humulin    NNP      (NP*))))))         -    -   -   -    (PRODUCT)           *)       *)  -
nw/wsj/06/wsj_0690   0   24               .      .             *))         -    -   -   -           *            *        *   -

nw/wsj/06/wsj_0690   0    0           Lilly   NNP   (TOP(S(NP*)      -    -   -   -    (ORG)      (ARG0*)            *   -
nw/wsj/06/wsj_0690   0    1              is   VBZ         (VP*       -    -   -   -       *            *             *   -
nw/wsj/06/wsj_0690   0    2        building   VBG         (VP*    build  01   -   -       *          (V*)            *   -
nw/wsj/06/wsj_0690   0    3          plants   NNS      (NP(NP*)      -    -   -   -       *       (ARG1*    (ARGM-LOC*)  -
nw/wsj/06/wsj_0690   0    4              to    TO  (SBAR(S(VP*       -    -   -   -       *            *             *   -
nw/wsj/06/wsj_0690   0    5            make    VB         (VP*     make  01   -   -       *            *           (V*)  -
nw/wsj/06/wsj_0690   0    6             the    DT         (NP*       -    -   -   -       *            *        (ARG1*   -
nw/wsj/06/wsj_0690   0    7         insulin    NN       *))))))      -    -   -   -       *            *)            *)  -
nw/wsj/06/wsj_0690   0    8              in    IN         (PP*       -    -   -   -       *   (ARGM-LOC*             *   -
nw/wsj/06/wsj_0690   0    9    Indianapolis   NNP      (NP(NP*)      -    -   -   -    (GPE)           *             *   -
nw/wsj/06/wsj_0690   0   10             and    CC            *       -    -   -   -       *            *             *   -
nw/wsj/06/wsj_0690   0   11      Fagershein   NNP      (NP(NP*)      -    -   -   -    (GPE)           *             *   -
nw/wsj/06/wsj_0690   0   12               ,     ,            *       -    -   -   -       *            *             *   -
nw/wsj/06/wsj_0690   0   13          France   NNP    (NP*))))))      -    -   -   -    (GPE)           *)            *   -
nw/wsj/06/wsj_0690   0   14               .     .           *))      -    -   -   -       *            *             *   -

nw/wsj/06/wsj_0690   0    0           In     IN   (TOP(S(PP*      -    -   -   -           *   (ARGM-LOC*        *   -
nw/wsj/06/wsj_0690   0    1          its   PRP$         (NP*      -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0    2       latest    JJS            *      -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0    3       annual     JJ            *      -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0    4       report     NN           *))     -    -   -   -           *            *)       *   -
nw/wsj/06/wsj_0690   0    5            ,      ,            *      -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0    6        Lilly    NNP         (NP*)     -    -   -   -        (ORG)      (ARG0*)       *   -
nw/wsj/06/wsj_0690   0    7         said    VBD         (VP*     say  01   -   -           *          (V*)       *   -
nw/wsj/06/wsj_0690   0    8      Humulin    NNP  (SBAR(S(NP*      -    -   -   -    (PRODUCT)      (ARG1*   (ARG0*   -
nw/wsj/06/wsj_0690   0    9        sales    NNS            *)     -    -   -   -           *            *        *)  -
nw/wsj/06/wsj_0690   0   10         have    VBP         (VP*      -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0   11        shown    VBN         (VP*    show  01   -   -           *            *      (V*)  -
nw/wsj/06/wsj_0690   0   12           ``     ``            *      -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0   13    excellent     JJ         (NP*      -    -   -   -           *            *   (ARG1*   -
nw/wsj/06/wsj_0690   0   14       growth     NN       *))))))     -    -   -   -           *            *)       *)  -
nw/wsj/06/wsj_0690   0   15            .      .            *      -    -   -   -           *            *        *   -
nw/wsj/06/wsj_0690   0   16           ''     ''           *))     -    -   -   -           *            *        *   -

nw/wsj/06/wsj_0690   0    0           Lilly   NNP       (TOP(S(NP*       -    -   -   -    (ORG)  (ARG0*         *        (ARG0*        *   -
nw/wsj/06/wsj_0690   0    1       officials   NNS                *)      -    -   -   -       *        *)        *             *)       *   -
nw/wsj/06/wsj_0690   0    2            said   VBD          (VP(VP*      say  01   -   -       *      (V*)        *             *        *   -
nw/wsj/06/wsj_0690   0    3            they   PRP      (SBAR(S(NP*)      -    -   -   -       *   (ARG1*    (ARG0*)            *        *   -
nw/wsj/06/wsj_0690   0    4             had   VBD             (VP*       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0    5            seen   VBN             (VP*      see  01   -   -       *        *       (V*)            *        *   -
nw/wsj/06/wsj_0690   0    6         reports   NNS          (NP(NP*)      -    -   -   -       *        *    (ARG1*             *        *   -
nw/wsj/06/wsj_0690   0    7              of    IN             (PP*       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0    8    hypoglycemic    JJ          (NP(NP*       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0    9     unawareness    NN                *)      -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   10           among    IN             (PP*       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   11            some    DT          (NP(NP*       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   12        patients   NNS                *)      -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   13          making   VBG             (VP*       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   14             the    DT          (NP(NP*       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   15           shift    NN                *)      -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   16            from    IN             (PP*       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   17          animal    JJ          (ADJP*))      -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   18              to    IN             (PP*       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   19           human    JJ             (NP*       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   20         insulin    NN   *))))))))))))))      -    -   -   -       *        *)        *)            *        *   -
nw/wsj/06/wsj_0690   0   21               ,     ,                *       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   22             but    CC                *       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   23             did   VBD             (VP*       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   24             n't    RB                *       -    -   -   -       *        *         *    (ARGM-NEG*)       *   -
nw/wsj/06/wsj_0690   0   25            know    VB             (VP*     know  01   1   -       *        *         *           (V*)       *   -
nw/wsj/06/wsj_0690   0   26              if    IN           (SBAR*       -    -   -   -       *        *         *        (ARG1*        *   -
nw/wsj/06/wsj_0690   0   27             the    DT           (S(NP*       -    -   -   -       *        *         *             *   (ARG0*   -
nw/wsj/06/wsj_0690   0   28         problem    NN                *)      -    -   -   -       *        *         *             *        *)  -
nw/wsj/06/wsj_0690   0   29             had   VBD             (VP*       -    -   -   -       *        *         *             *        *   -
nw/wsj/06/wsj_0690   0   30          caused   VBN             (VP*    cause  01   1   -       *        *         *             *      (V*)  -
nw/wsj/06/wsj_0690   0   31             any    DT             (NP*       -    -   -   -       *        *         *             *   (ARG1*   -
nw/wsj/06/wsj_0690   0   32          deaths   NNS         *))))))))      -    -   -   -       *        *         *             *)       *)  -
nw/wsj/06/wsj_0690   0   33               .     .               *))      -    -   -   -       *        *         *             *        *   -

nw/wsj/06/wsj_0690   0    0             Dr.    NNP      (TOP(S(NP(NP*          -    -   -   -          *   (ARG0*        *   -
nw/wsj/06/wsj_0690   0    1           Leigh    NNP                  *          -    -   -   -   (PERSON*        *        *   -
nw/wsj/06/wsj_0690   0    2        Thompson    NNP                  *)         -    -   -   -          *)       *        *   -
nw/wsj/06/wsj_0690   0    3               ,      ,                  *          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0    4               a     DT               (NP*          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0    5           Lilly    NNP              (NML*          -    -   -   -       (ORG)       *        *   -
nw/wsj/06/wsj_0690   0    6           group     NN                  *)         -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0    7            vice     NN                  *          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0    8       president     NN                  *)         -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0    9               ,      ,                  *)         -    -   -   -          *        *)       *   -
nw/wsj/06/wsj_0690   0   10            said    VBD               (VP*         say  01   -   -          *      (V*)       *   -
nw/wsj/06/wsj_0690   0   11             the     DT  (SBAR(S(NP(NP(NP*          -    -   -   -          *   (ARG1*   (ARG0*   -
nw/wsj/06/wsj_0690   0   12         company     NN                  *          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   13              's    POS                  *)         -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   14        clinical     JJ                  *          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   15          trials    NNS                  *)         -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   16              of     IN               (PP*          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   17            both     CC               (NP*          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   18             its   PRP$                  *          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   19          animal     NN         (ADJP(NML*          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   20             and     CC                  *          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   21           human     NN                  *)         -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   22              -    HYPH                  *          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   23           based    VBN                  *)         -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   24        insulins    NNS                *)))         -    -   -   -          *        *        *)  -
nw/wsj/06/wsj_0690   0   25       indicated    VBD               (VP*    indicate  01   -   -          *        *      (V*)  -
nw/wsj/06/wsj_0690   0   26              no     DT            (NP(NP*          -    -   -   -          *        *   (ARG1*   -
nw/wsj/06/wsj_0690   0   27      difference     NN                  *)         -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   28              in     IN               (PP*          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   29             the     DT            (NP(NP*          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   30           level     NN                  *)         -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   31              of     IN               (PP*          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   32    hypoglycemia     NN            (NP*))))         -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   33         between     IN               (PP*          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   34           users    NNS            (NP(NP*)         -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   35              of     IN               (PP*          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   36          either     DT               (NP*          -    -   -   -          *        *        *   -
nw/wsj/06/wsj_0690   0   37         product     NN          *)))))))))         -    -   -   -          *        *)       *)  -
nw/wsj/06/wsj_0690   0   38               .      .                 *))         -    -   -   -          *        *        *   -

nw/wsj/06/wsj_0690   0    0             Dr.    NNP          (TOP(S(NP*      -    -   -   -          *   (ARG0*           *        *        *   -
nw/wsj/06/wsj_0690   0    1        Toseland    NNP                   *)     -    -   -   -    (PERSON)       *)          *        *        *   -
nw/wsj/06/wsj_0690   0    2            said    VBD                (VP*     say  01   -   -          *      (V*)          *        *        *   -
nw/wsj/06/wsj_0690   0    3            most    JJS   (SBAR(S(NP(NP(NP*)     -    -   -   -          *   (ARG1*      (ARG1*   (ARG0*        *   -
nw/wsj/06/wsj_0690   0    4              of     IN                (PP*      -    -   -   -          *        *           *        *        *   -
nw/wsj/06/wsj_0690   0    5             the     DT                (NP*      -    -   -   -          *        *           *        *        *   -
nw/wsj/06/wsj_0690   0    6         British     JJ                   *      -    -   -   -      (NORP)       *           *        *        *   -
nw/wsj/06/wsj_0690   0    7       diabetics    NNS                 *)))     -    -   -   -          *        *           *)       *        *   -
nw/wsj/06/wsj_0690   0    8             who     WP         (SBAR(WHNP*)     -    -   -   -          *        *    (R-ARG1*)       *        *   -
nw/wsj/06/wsj_0690   0    9            died    VBD           (S(VP*))))    die  01   -   -          *        *         (V*)       *)       *   -
nw/wsj/06/wsj_0690   0   10             had    VBD                (VP*      -    -   -   -          *        *           *        *        *   -
nw/wsj/06/wsj_0690   0   11            been    VBN                (VP*      -    -   -   -          *        *           *        *        *   -
nw/wsj/06/wsj_0690   0   12          taking    VBG                (VP*    take  01   -   -          *        *           *      (V*)       *   -
nw/wsj/06/wsj_0690   0   13               a     DT             (NP(NP*      -    -   -   -          *        *           *   (ARG1*   (ARG1*   -
nw/wsj/06/wsj_0690   0   14           human     NN              (ADJP*      -    -   -   -          *        *           *        *        *   -
nw/wsj/06/wsj_0690   0   15              -    HYPH                   *      -    -   -   -          *        *           *        *        *   -
nw/wsj/06/wsj_0690   0   16           based    VBN                   *)     -    -   -   -          *        *           *        *        *   -
nw/wsj/06/wsj_0690   0   17         insulin     NN                   *)     -    -   -   -          *        *           *        *        *)  -
nw/wsj/06/wsj_0690   0   18            made    VBN                (VP*    make  01   -   -          *        *           *        *      (V*)  -
nw/wsj/06/wsj_0690   0   19              by     IN                (PP*      -    -   -   -          *        *           *        *   (ARG0*   -
nw/wsj/06/wsj_0690   0   20            Novo    NNP             (NP(NP*      -    -   -   -      (ORG*        *           *        *        *   -
nw/wsj/06/wsj_0690   0   21               /    SYM                   *      -    -   -   -          *        *           *        *        *   -
nw/wsj/06/wsj_0690   0   22         Nordisk    NNP                   *)     -    -   -   -          *)       *           *        *        *   -
nw/wsj/06/wsj_0690   0   23               ,      ,                   *      -    -   -   -          *        *           *        *        *   -
nw/wsj/06/wsj_0690   0   24               a     DT                (NP*      -    -   -   -          *        *           *        *        *   -
nw/wsj/06/wsj_0690   0   25          Danish     JJ                   *      -    -   -   -      (NORP)       *           *        *        *   -
nw/wsj/06/wsj_0690   0   26    manufacturer     NN         *)))))))))))     -    -   -   -          *        *)          *        *)       *)  -
nw/wsj/06/wsj_0690   0   27               .      .                  *))     -    -   -   -          *        *           *        *        *   -

nw/wsj/06/wsj_0690   0   0         None    NN   (TOP(S(NP(NP*)    -    -   -   -       *   (ARG0*   -
nw/wsj/06/wsj_0690   0   1           of    IN            (PP*     -    -   -   -       *        *   -
nw/wsj/06/wsj_0690   0   2          the    DT            (NP*     -    -   -   -       *        *   -
nw/wsj/06/wsj_0690   0   3    diabetics   NNS             *)))    -    -   -   -       *        *)  -
nw/wsj/06/wsj_0690   0   4         were   VBD            (VP*     -    -   -   -       *        *   -
nw/wsj/06/wsj_0690   0   5        using   VBG            (VP*    use  01   -   -       *      (V*)  -
nw/wsj/06/wsj_0690   0   6        Lilly   NNP         (NP(NP*     -    -   -   -    (ORG)  (ARG1*   -
nw/wsj/06/wsj_0690   0   7           's   POS               *)    -    -   -   -       *        *   -
nw/wsj/06/wsj_0690   0   8      insulin    NN             *)))    -    -   -   -       *        *)  -
nw/wsj/06/wsj_0690   0   9            .     .              *))    -    -   -   -       *        *   -

#end document
